Assurant is a strong dividend growth investment. Currently undervalued with a fair value estimate of $226.80. See why we ...

Clover Health Investments (NASDAQ:CLOV – Free Report) had its target price raised by Canaccord Genuity Group from $4.20 to $4.50 in a research report report published on Monday morning,Benzinga ...

Analysts at Zacks Research lowered their Q1 2026 earnings estimates for shares of Elevance Health in a report released on Thursday, February 27th. Zacks Research analyst K. Dey now forecasts that the ...

is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Earnings Per Share (TTM ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

How the 47th president leads the US on inflation, immigration and other areas will define his legacy. These data points show ...

After a solid January, the S&P 500 stumbled in February on concerns about slowing economic growth and a growing trade war.

Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced its operating and financial results for the fourth quarter and full year of 2024. Whitestone creates neighborhood center ...

Citizens JMP raised the firm’s price target on American Healthcare REIT (AHR) to $35 from $30 and keeps an Outperform rating on the shares.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Humana (NYSE:HUM) priced a public offering of $1.25B in aggregate principal amount of senior notes. These senior notes are comprised of $750M of the company’s 5.55% senior notes, due 2035, at 99.885% ...

Health-care company stocks were among the few gainers in Wall Street Monday, after Health and Human Services Secretary Robert F. Kennedy Jr. expressed support for vaccines as a way to fight a measles ...